Source:http://linkedlifedata.com/resource/pubmed/id/18562428
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2009-5-12
|
pubmed:abstractText |
Depression is diagnosed in 15-30% of patients following myocardial infarction (MI) and this may also be observed in the rat. We measured the effects of the antidepressant sertraline on behavioural and biochemical events following MI in a rat model. Following surgery, MI rats and sham controls were treated with sertraline (10 mg/kg, i.p.) or saline. Subgroups of rats were tested for behavioural depression 14 days after surgery. Apoptosis was estimated in other rats by measuring caspase-3 activity and TUNEL positive cells (3 days after surgery) in limbic structures (amygdale, hippocampus, hypothalamus, frontal and prefrontal cortices). Bax/Bcl-2 ratio was measured 14 days after surgery. Behavioural signs of depression (decreased sucrose intake and forced swimming time) were found in saline-treated MI rats but not in sertraline-treated rats. Compared with controls, caspase-3 activity and TUNEL positive cells were significantly increased in most limbic structures of MI rats. High prefrontal Bax/Bcl-2 ratio in MI rats correlated with low forced swimming time. Apoptosis was not found in sertraline-treated MI rats. These results establish the bases of a rat model of depression following MI and show for the first time that a selective serotonin reuptake inhibitor prevents both behavioural and biochemical markers in this model.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antidepressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers,
http://linkedlifedata.com/resource/pubmed/chemical/Caspase 3,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2,
http://linkedlifedata.com/resource/pubmed/chemical/Sertraline,
http://linkedlifedata.com/resource/pubmed/chemical/bcl-2-Associated X Protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0269-8811
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
451-9
|
pubmed:meshHeading |
pubmed-meshheading:18562428-Animals,
pubmed-meshheading:18562428-Antidepressive Agents,
pubmed-meshheading:18562428-Apoptosis,
pubmed-meshheading:18562428-Behavior, Animal,
pubmed-meshheading:18562428-Biological Markers,
pubmed-meshheading:18562428-Caspase 3,
pubmed-meshheading:18562428-DNA Fragmentation,
pubmed-meshheading:18562428-Depression,
pubmed-meshheading:18562428-Limbic System,
pubmed-meshheading:18562428-Male,
pubmed-meshheading:18562428-Myocardial Infarction,
pubmed-meshheading:18562428-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:18562428-Rats,
pubmed-meshheading:18562428-Rats, Sprague-Dawley,
pubmed-meshheading:18562428-Sertraline,
pubmed-meshheading:18562428-bcl-2-Associated X Protein
|
pubmed:year |
2009
|
pubmed:articleTitle |
Behavioural signs of depression and apoptosis in the limbic system following myocardial infarction: effects of sertraline.
|
pubmed:affiliation |
Centre de recherche, Hôpital Sacré-Coeur de Montréal, Montréal, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|